Compare PCRX & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | MBWM |
|---|---|---|
| Founded | 2006 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 862.3M |
| IPO Year | 2010 | 1997 |
| Metric | PCRX | MBWM |
|---|---|---|
| Price | $23.21 | $50.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $37.60 | ★ $53.63 |
| AVG Volume (30 Days) | ★ 754.0K | 81.8K |
| Earning Date | 05-15-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.13% |
| EPS Growth | ★ 107.44 | 10.95 |
| EPS | 0.16 | ★ 5.47 |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $9.77 | $20.28 |
| Revenue Next Year | $9.71 | $4.67 |
| P/E Ratio | $145.38 | ★ $9.13 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $37.76 |
| 52 Week High | $27.99 | $55.77 |
| Indicator | PCRX | MBWM |
|---|---|---|
| Relative Strength Index (RSI) | 52.99 | 39.54 |
| Support Level | $20.09 | $49.95 |
| Resistance Level | $24.65 | $50.36 |
| Average True Range (ATR) | 1.11 | 1.63 |
| MACD | 0.06 | -0.34 |
| Stochastic Oscillator | 66.38 | 29.20 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.